MDArena: Evaluating Coding Agents on Realistic Molecular Dynamics Workflows
On the map: LLM agents and tool use → Medical and scientific domain agents
Abstract (arXiv)
Accelerating scientific discovery is among the most consequential applications of AI, and computational biomolecular simulation stands out as a particularly promising target within this broader effort. Coding agents promise to automate significant portions of this workflow, yet their reliability on realistic molecular dynamics (MD) tasks remains poorly characterized. To address this issue, we introduce MDArena, a benchmark of 50 containerized tasks drawn from active biomolecular simulation projects, spanning 29 molecular systems and 14 broad research protocols, including trajectory analysis, complex system preparation, free-energy protocols, and enhanced sampling. We evaluate six model/harness configurations spanning Codex and OpenCode. Among the evaluated configurations, Codex GPT-5.5 at extra-high reasoning effort performs best, reaching 24/50 Strict-Pass@1 successes (48%), followed by Codex GPT-5.5 Medium with 21/50, and OpenCode Gemini Flash 3.5 with 20/50. Average correctness and process rewards are substantially higher than strict success rates across all configurations, indicating that agents frequently make meaningful partial progress but fail on the fine-grained details required for reproducible scientific workflows. Hard tasks remain largely unsolved, particularly membrane-protein system preparation and alchemical free-energy setup, both unsolved or near-unsolved by every evaluated configuration. MDArena thus exposes a substantial gap between the usefulness of coding agents as supervised assistants and their reliability as autonomous MD researchers, while providing a reproducible and extensible platform for tracking progress toward closing it.
Key facts. Cited by 2 papers in the map (data through 14 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. Builds on 15 of its 40 references that are in the map. First posted on arXiv 31 Jul 2026.
Builds on
15 of 40 references.
Closest ancestors · 1
Same direction, newest first
Other references · 14
- 2023A Survey of Large Language Modelscited by 2,576
- 2024SWE-agent: Agent-Computer Interfaces Enable Automated Software Engineeringcited by 1,737
- 2024OpenHands: An Open Platform for AI Software Developers as Generalist Agentscited by 1,002
- 2026Meta-Harness: End-to-End Optimization of Model Harnessescited by 309
- 2024Large Language Model-Based Agents for Software Engineering: A Surveycited by 178
- 2026Agentic Harness Engineering: Observability-Driven Automatic Evolution of Coding-Agent Harnessescited by 142
- 2022OpenFE: Automated Feature Generation with Expert-level Performancecited by 52
- 2023OpenMM 8: Molecular Dynamics Simulation with Machine Learning Potentialscited by 47
- 2026Harness Updating Is Not Harness Benefit: Disentangling Evolution Capabilities in Self-Evolving LLM Agentscited by 34
- 2025MDCrow: Automating Molecular Dynamics Workflows with Large Language Modelscited by 22
- 2026MDAgent2: Large Language Model for Code Generation and Knowledge Q&A in Molecular Dynamicscited by 7
- 2025DynaMate: An Autonomous Agent for Protein-Ligand Molecular Dynamics Simulationscited by 6
Built on by
Citing papers per year: 2026: 2.
2 papers.
Similar, not cited
Close in wording, no citation either way
- 2026MDForge: Agentic Molecular Dynamics Pipeline Design under Sparse Simulator Feedback
- 2026CAi Copilot: Reducing Operational Workload in Molecular Design through Intent-Driven Agentic Workflows
- 2026AgentFold: Closed-Loop Agentic Search for Protein Folding Model Design
- 2026AutoNovo: Agentic Program Search Discovers Transferable Nucleic Acid Design Algorithms
- 2024AgentDrug: Utilizing Large Language Models in An Agentic Workflow for Zero-Shot Molecular Editing
- 2026Molecular LLM Agents: From Architectural Design to Scientific Autonomy
- 2026Evaluating Agentic Bioinformatics through Function, Evidence, and Validation
- 2026Toward a Locally Deployable Agentic Co-Scientist: Small-Model Planning for Early-Stage Drug Discovery